CAR-CF an international study on #COVID-19 Antibody Response in Cystic Fibrosis
Updated: Sep 5, 2022
Dr Helen Barr of the NIHR Nottingham Biomedical Research Centre, will shortly commence recruitment into the CAR-CF study at NUH Nottingham, which will measure #COVID-19 antibody levels in thousands of people with cystic fibrosis across 17 European countries and is funded by a $1.5m grant from the CF Foundation (US) over a two-year period.
The study is being led by researchers at Queen’s University Belfast at their Wellcome-Wolfson Institute for Experimental Medicine (WWIEM).
The project will also run in Canada and the US, making the research the largest prospective study in cystic fibrosis (CF) to have been carried out to date.